Clinical studies of certain FDA-approved GLP-1 medications show differences in average weight loss compared to phentermine
The evidence for body-weight reduction is mixed
Obesity triggers adipose tissue alterations leading to adipose tissue dysfunction, characterized by an unhealthy expansion along with inflammation, fibrosis, hypoxia and altered adipokine secretion
Compound GLP-1 Branded GLP-1 Agonists like Ozempic, Saxenda, and Wegovy are rigorously tested and approved by regulatory bodies such as the U.S
The FDA approved semaglutide specifically for type 2 diabetes management, not weight loss, which creates a legal and ethical barrier for many physicians
Make sure you have everything ready and in front of you before you begin, which should include an alcohol swab or two and your syringe